| CAS NO: | 187389-52-2 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 1mg | 询价 |
| 2mg | 询价 |
| 5mg | 询价 |
| 10mg | 询价 |
| 25mg | 询价 |
| 50mg | 询价 |
| 100mg | 询价 |
| 250mg | 询价 |
| 500mg | 询价 |
| Molecular Weight (MW) | 467.49 |
|---|---|
| Formula | C22H30FN3O7 |
| CAS No. | 187389-52-2 |
| Storage | -20℃ for 3 years in powder form |
| -80℃ for 2 years in solvent | |
| Solubility (In vitro) | DMSO: 93 mg/mL (198 mM) |
| Water:<1 mg/mL (slightly soluble or insoluble) | |
| Ethanol: 24 mg/mL warming (51 mM) | |
| Other info | Synonym: Z-VAD-FMK; Z-VAD(OMe)-FMK; Z-Val-Ala-Asp(OMe)-FMK; Z VADFMK; ZVADFMK. Chemical Name: methyl (3S)-5-fluoro-3-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoyl]amino]-4-oxopentanoate SMILES Code: O=C(OC)C[C@H](NC([C@@H](NC([C@@H](NC(OCC1=CC=CC=C1)=O)C(C)C)=O)C)=O)C(CF)=O |
| In Vitro | Z-VAD-FMK (10 mM) inhibits apoptosis in THP.1 cells. Z-VAD-FMK (10 μM) inhibits activation of PARP protease activity in control THP.1 cell lysates. |
|---|---|
| In Vivo | The right ear swelling degree, weight differences and thickness between two ears in the 1.25 mML Z-VAD-FMK group were significantly lower than those of the negative control (NC). The levels of INF-γ and IL-2 in the ear skin lesions, the mean intensity of BrdU in T lymphocytes, and the percent of activation markers-positive T lymphocytes were all lower than those of NC. |
| Animal model | C57BL mice |
| Formulation & Dosage | 1.25 mMl; Ear provocation |
| References | Zhonghua Yi Xue Za Zhi. 2012 Jul 24;92(28):1992-6. |
|
|
|
|
| 维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |
